Nonetheless, KMO inhibition still holds promise for treatment of disorders such as Alzheimer’s and Parkinson’s diseases, where amelioration of disease phenotypes has been observed in fruit fly and mouse models of these disorders11,13. Here, KMO is linked to Parkinson disease.